Advertisement

Related Videos

Deborah Collyar: What's In It for Patients?

Mark J. Ratain, MD: The Justification for a Randomized Trial of Low-Dose Ibrutinib

David A. Hyman, MD, JD, on Inclusive Shared Savings

Blase Polite, MD, MPP, FASCO, on Transforming the Drug Cost Curve in the United States: Not How But If

Kelvin Chan, MD, FRCPC, MSc, PhD, on Opportunities to Optimize Cancer Drug Policies: The Canadian Perspective

Advertisement

Advertisement




Feb
18
Today In Oncology
Colorectal Cancer How Does Lifetime Alcohol Consumption Affect Risk
New Report Shows Colorectal Cancer is Now Leading Cancer Death Among Those Under 50
Can Color Vision Deficiency Impact Survival in Bladder or Colorectal Cancer
Cancer Surgery Outcomes Similar Between Rural and Urban Facilities
Cardiovascular Effects and Risk Factors Identified With BRAF and MEK Inhibition in Melanoma
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo